002422 科倫藥業
按盤價 
30.580 +0.100 (+0.328%)
30.580 +0.100 (+0.328%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.703 | 13.874 | 11.526 | 8.061 | 6.216 |
| 總資產報酬率 ROA (%) | 6.603 | 6.952 | 5.188 | 3.471 | 2.614 |
| 投入資產回報率 ROIC (%) | 8.787 | 8.957 | 6.621 | 4.357 | 3.332 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.508 | 52.430 | 52.516 | 55.664 | 54.247 |
| 營業利潤率 (%) | 22.694 | 17.033 | 11.530 | 7.639 | 6.134 |
| 息稅前利潤/營業總收入 (%) | 22.397 | 17.779 | 13.382 | 9.743 | 9.399 |
| 淨利潤/營業總收入 (%) | 17.399 | 12.336 | 8.952 | 5.025 | 4.807 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.045 | 88.720 | 87.756 | 83.807 | 75.268 |
| 價值變動淨收益/利潤總額(%) | 8.148 | 10.433 | 11.821 | 18.653 | 9.973 |
| 營業外收支淨額/利潤總額(%) | -2.815 | -2.059 | -6.152 | -12.078 | -5.752 | 償債能力分析 |
| 流動比率 (X) | 1.880 | 1.830 | 1.376 | 1.045 | 1.199 |
| 速動比率 (X) | 1.555 | 1.446 | 1.110 | 0.794 | 0.916 |
| 資產負債率 (%) | 31.675 | 36.866 | 50.678 | 55.201 | 0.562 |
| 帶息債務/全部投入資本 (%) | 15.642 | 27.324 | 39.040 | 42.213 | 45.204 |
| 股東權益/帶息債務 (%) | 513.609 | 255.616 | 151.090 | 132.162 | 115.874 |
| 股東權益/負債合計 (%) | 185.471 | 146.379 | 90.766 | 79.589 | 75.078 |
| 利息保障倍數 (X) | 68.988 | 16.317 | 5.310 | 3.329 | 2.612 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 75.707 | 87.082 | 103.975 | 114.391 | 132.940 |
| 存貨周轉天數 (天) | 120.774 | 124.413 | 130.958 | 160.520 | 163.786 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/12/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
